This article is published in association with European Investment Bank. The European investment bank (EIB) and Fabentech, a leading French biopharmaceutical company specializing in the development and production of therapeutics against biological threats, have signed a €20 million financing under the HERA Invest mechanism. This €100 million initiative is part of the European Health Union and […]France: Biopharma Fabentech gets a €20 million EIB loan to advance preparedness against pandemics and biological threats
October 7, 2024 by Leave a Comment
This article is published in association with European Investment Bank. The European investment bank (EIB) and Fabentech, a leading French biopharmaceutical company specializing in the development and production of therapeutics against biological threats, have signed a €20 million financing under the HERA Invest mechanism. This €100 million initiative is part of the European Health Union and […]
